Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA). (Q34263701)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

title

Antiviral and immunological benefits in HIV patients receiving intranasal peptide T (DAPTA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

2

Francis W Ruscetti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

author name string

Maria T Polianova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Candace B Pert

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Rochelle E Tractenberg

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Gifford Leoung

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

Scott Strang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

number of pages

6

1 reference

inferred from page(s)

published in

Peptides

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

page(s)

1093-1098

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults

19 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

The challenge of viral reservoirs in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Treatment of early AIDS dementia in intravenous drug users: high versus low dose peptide T

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Impact of antiretroviral therapy and changes in virus load on human immunodeficiency virus (HIV)-specific T cell responses in primary HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Human immunodeficiency virus type 1 protease inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression. Australian Long-Term Nonprogressor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5).

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Update on D-ala-peptide T-amide (DAPTA): a viral entry inhibitor that blocks CCR5 chemokine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Stability in controlling viral replication identifies long-term nonprogressors as a distinct subgroup among human immunodeficiency virus type 1-infected persons.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

Peptide T in treatment of AIDS

1 reference

https://api.crossref.org/works/10.1016%2FS0196-9781%2803%2900176-1

7 January 2021

10.1016/S0196-9781(03)00176-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14499289%20AND%20SRC:MED&resulttype=core&format=json

19 December 2019

1 reference